OKUR OnKure Therapeutics Inc.

Price (delayed)

$2.94

Market cap

$119.06M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.5

Enterprise value

-$46.52M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 5
Highlights
The quick ratio has soared by 142% YoY and by 98% from the previous quarter
OnKure Therapeutics's net income has increased by 2.7% YoY
The equity has soared by 120% year-on-year but it is down by 7% since the previous quarter
OKUR's EPS has dropped by 106% year-on-year but it is up by 19% since the previous quarter
OKUR's debt has surged by 126% since the previous quarter and by 13% year-on-year

Key stats

What are the main financial stats of OKUR

OKUR stock price

How has the OnKure Therapeutics stock price performed over time
Intraday
-5.16%
1 week
2.08%
1 month
-25.38%
1 year
16.21%
YTD
1.38%
QTD
-35.53%

Financial performance

How have OnKure Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$62.14M
Net income
-$58.71M
Gross margin
N/A
Net margin
N/A
OnKure Therapeutics's net income has increased by 2.7% YoY
OnKure Therapeutics's operating income has increased by 2.2% YoY

Price vs fundamentals

How does OKUR's price correlate with its fundamentals

Growth

What is OnKure Therapeutics's growth rate over time

Valuation

What is OnKure Therapeutics stock price valuation
P/E
N/A
P/B
0.69
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
OKUR's EPS has dropped by 106% year-on-year but it is up by 19% since the previous quarter
The equity has soared by 120% year-on-year but it is down by 7% since the previous quarter
The P/B is 19% less than the 5-year quarterly average of 0.9 but 4.3% more than the last 4 quarters average of 0.7

Efficiency

How efficient is OnKure Therapeutics business performance
OKUR's ROE is up by 30% year-on-year and by 20% since the previous quarter
OKUR's ROA is up by 28% year-on-year and by 18% since the previous quarter

Dividends

What is OKUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OKUR.

Financial health

How did OnKure Therapeutics financials performed over time
The quick ratio has soared by 142% YoY and by 98% from the previous quarter
OnKure Therapeutics's current ratio has soared by 140% YoY and by 94% from the previous quarter
OKUR's debt is 99% smaller than its equity
OKUR's debt has surged by 126% since the previous quarter and by 13% year-on-year
The equity has soared by 120% year-on-year but it is down by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.